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‘Human Clones Talk About Their Lives’1: Media Representations of 
Assisted Reproductive and Biogenetic Technologies 
 
 
Abstract  
 
This paper examines New Zealand print media representations of assisted reproductive 
and related biogenetic technologies, conceptualised as the products of a concordance of 
interest between media workers and reproductive specialists, biogenetic scientists, and 
consumers. Such concordance is evident in the predominant use of media frames of 
anecdotal personalisation and technoboosterism, which typically amplify the voices of 
proponents of emerging technologies whilst marginalising and delegitimising 
counterdiscourses. Thus, the perspectives of consumers and ‘expert’ sources are 
privileged at the expense of a more balanced assessment of the value and social, ethical, 
legal and health implications of assisted reproductive and related biogenetic technologies. 
Source dependence also detracts from much-needed recognition of the professional and 
financial interests at stake in the growing privatisation and commercialisation of these 
technologies, and in the local context potentially undermines journalistic independence 
and integrity. 
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Introduction 
 
The 1978 birth of the world’s first ‘test tube’2 baby sparked extensive public debate about 
the social and ethical implications of in vitro fertilisation and other human assisted 
reproductive technologies (ARTs). In New Zealand, some greeted the news with wonder 
and a burgeoning respect for the doctors performing such generative miracles, while 
others expressed unease at doctors ‘playing God’ by created life artificially in a 
laboratory (NZ Law Reform Division, 1986; Daniels, 1988). Concerns were raised about 
the possible health risks and unknown effects of IVF (Bunkle, 1988; Coney and Else, 
1999), while others highlighted the troubling nature and potential future objectives of 
biomedical exploration, along with the need for greater regulation of this area (New 
Zealand Law Reform Division, 1986; Batty, 2002).  
Early ambivalence has since evolved into widespread public acceptance of most 
ARTs, now commonly perceived as routine ‘every-day’ miracles helping infertile couples 
attain a longed-for child. In many respects, however, IVF was merely the ‘founding 
episode of the “biology revolution”’ (Seguin, 2001: 199), which has renewed public 
interest and concern (Van Dijck, 1998). Current anxieties centre on techniques that merge 
reproductive and biogenetic technologies, such as the use of pre-implantation genetic 
diagnosis (PGD) to produce ‘saviour siblings’ and ‘designer babies’, xenotransplantation, 
human embryo cloning for stem cell research, and the ‘spectre’ of human reproductive 
cloning.3 Disturbed by the implications of these developments and following the lead of 
the United Kingdom, Australia, and Canada, the New Zealand government recently 
introduced the Human Assisted Reproductive Technology (HART) Act 2004 banning 
human cloning for reproductive purposes whilst also outlawing the implantation of 
human/animal hybrids, the use of PGD for sex selection, and commercial surrogacy.4 
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Largely due to expediency, the HART Act does not address the controversial issue of 
stem cell research. The scope of this legislation does, however, reflect the increasing 
intersection between reproductive and biogenetic technologies and related research.  
Acknowledging this growing coincidence, the focus of the present study is on 
New Zealand print media representations of ARTs, related biogenetic technologies, stem 
cell research, and cloning during the periods 1st May 2002 to 1st September 2003, and 
from 1st July to 1st December 2004. These periods represent two key stages during which 
the HART Act 2004 was being considered by the Health Select Committee, subjected to 
intensive scrutiny both by media and a public submission process, and read and debated 
in Parliament for the third and final time. Hence, this study was conducted within the 
context of considerable public and political debate over the nature, intent and 
implications of both the technologies themselves, and the scope of proposed legislation. 
 
 
A Concordance of Interest 
 
Understanding media representations of these technologies is important, for as 
Väliverronen (2004: 363) notes, media are a key site for the production and dissemination 
of cultural images of emerging biogenetic technologies and related research. Media also 
comprise a major source of information used by individuals, interest groups and decision-
makers to construct understandings of the social and policy issues raised by new 
scientific and medical developments, which are generally outside most people’s direct 
experience (Nelkin, 1987; Conrad, 1997; Petersen, 2001; Nisbet and Lewenstein, 2002). 
Media thus play a key role in shaping the way such issues come to be ‘defined and 
symbolized’ (Nisbet and Lewenstein, 2002: 360), and on that basis, regulated, as media 
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derived understandings clearly do inform private and political action. As found by Rayna 
Rapp (1988), women frequently refer to mass media for information about new 
technologies such as amniocentesis, and incorporate this knowledge into the doctor--
patient encounter. Similarly, Sarah Franklin (1990: 201) notes that media representations 
comprise ‘an important public source of both formal knowledge and commonsense 
understandings of the experience of infertility and the rapidly expanding field of “test-
tube baby” science…. As such, they have considerable influence upon public opinion and 
parliamentary debate’. In this light, how media frame assisted reproductive and 
biogenetic technologies clearly assumes wider significance.  
In what follows, I consider the respective roles of journalists, reproductive 
specialists, biogenetic scientists, and consumers in ‘framing’ the content and scope of 
media representations of the technologies, practices and research now regulated under the 
HART Act 2004. As discussed by Todd Gitlin (1980: 7), ‘Media frames are persistent 
patterns of cognition, interpretation, and presentation, of selection, emphasis, and 
exclusion, by which symbol handlers routinely organize discourse, whether visual or 
verbal’, which aid readers in understanding the essence of the issue, its context and 
meaning (Weingart, 1998). As Corner et al. (1990) and Philo (1990, 1993) suggest, news 
stories may actively ‘frame’ issues in ways that legitimate particular understandings of 
them, whilst simultaneously excluding or downplaying other possible explanations, 
thereby narrowing the scope of public debate. Condit (1994) also notes the tendency of 
media to ‘amplify’ certain voices while silencing others.  
Among the voices most often amplified in media coverage of these technologies 
are those of reproductive specialists, biogenetic scientists, and consumers. Members of 
these groups are often key sources for health and science reporters, and in many respects, 
a symbiotic relationship (Karpf, 1988; Weingart, 1998; Michelle, 2006a) or concordance 
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of interest (Condit, 1994) exists between them. For their part, journalists increasingly rely 
on the ‘knowledge capital’ and institutional authority of highly qualified specialists and 
scientists to lend credibility to reports on new developments in emerging fields. 
Particularly so in the New Zealand context,5 journalists often have limited scientific 
training in areas that are rapidly evolving in extremely complex ways, and so rely on 
these key sources for ‘clarification’ of the nature and importance of a new development 
and the issues it raises (Friedman, 1986; Nelkin, 1987; Karpf, 1988; Dunwoody, 1986; 
Van Dijck, 1995). As noted by Condit (1994), specialists, scientists and researchers also 
provide reporters with stories about cutting-edge research and emerging technological 
developments that are inherently newsworthy, thus offering journalists and editors what 
they need: interesting and topical stories that help sell newspapers and magazines. 
In return, journalists offer media-savvy specialists and scientists the opportunity 
to shape public perceptions of research and development in their respective areas, and to 
foster public and official enthusiasm for their work, in turn aiding the process of securing 
funding (Dunwoody, 1986; Nelkin, 1987; Karpf, 1988; Petersen, 2001). As noted by Zehr 
(1999: 8), science journalism plays an important role for the scientific project by 
providing scientists with ‘unique opportunities to defend and augment their authoritative 
position in society’. Increasingly, scientists and (bio)medical organisations seek to 
influence news media by hiring professional communications managers to handle media 
interactions, issuing press releases highlighting medical breakthroughs or new services, 
providing journalists with information packages, establishing websites, and actively 
lobbying media workers to cover issues in ways that uphold their interests, deflect 
potential criticism, and help maintain their authority and autonomy (Friedman, 1986; 
Nelkin, 1987, 2001; Karpf, 1988; Lewenstein, 1995; Van Dijck, 1998; Nerlich et al., 
2002; Nisbet and Lewenstein, 2002; Väliverronen, 2004; Michelle, 2006a). Such active 
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media management is increasingly necessary to allay public anxieties over controversial 
developments such as genetic modification, stem cell research and human cloning. As 
Weingart (1998: 871) notes, ‘the stronger the dependence of science on public consent, 
the more important is attention and consent of the media’ (see also Nelkin, 1996). 
Because of this concordance of interest, scientists and specialists have become a 
powerful interest group that has considerable input into, and thus capacity to manipulate, 
media representations of new biomedical developments (see Michelle 2006a for further 
discussion in the local context). While media personnel obviously retain considerable 
editorial independence, the highly specialised nature of emerging innovations means 
journalists are increasingly reliant on reiterating the same terms, metaphors, images, 
rhetorical strategies and frameworks of understanding used by scientists and medical 
specialists themselves in relating the nature and value of their work (Nelkin, 1987; 
Petersen, 2001; Van Dijck, 1995; Väliverronen, 2004; Michelle, 2006a). As found by 
Smart (2003), this ‘source dependence’ often means that those actively involved in 
developing a biotechnology or related application become key sources of information 
about its ethical, legal and social implications. In this respect, there is potential for media 
to serve as a conduit through which scientists, specialists and medico--scientific 
organisations may attempt to assert the legitimacy of, and win consent to, their shared 
worldview or ‘regime of truth’ by way of controlling how particular issues and new 
developments are represented to the general public (see also Corner et al., 1990).6 As 
Michel Foucault (1971: 221) suggests, ‘discourse is the power which is to be seized’, and 
by influencing the way new developments are discursively framed and represented in 
media, these interest groups may exert considerable power over public and political 
responses to them. Potentially, they are able to set the agenda for subsequent discussion 
and debate on their own terms. 
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A similar concordance of interest also exists between journalists and consumers, 
with the latter group often providing highly newsworthy stories (Condit, 1994). As noted 
by Karpf (1988), Petersen (2001), and Conrad (1997), finding the human interest angle 
behind a complex new medical or scientific development is a common journalistic 
technique used to create interest and make ‘high-tech’ procedures and technologies more 
relevant and personally meaningful to lay audiences. Such stories require less time to 
research and write, and are often emotionally compelling and highly ‘readable’, making 
them attractive to a general audience and in turn boosting sales (Cook, 1998 and 
Patterson, 2001, as cited in Nisbet et al., 2003). Further, in the New Zealand context, 
competition for market share is especially fierce (Bell, 1995; Lealand, 2004), and 
decisions about which ‘frame’ or angle to adopt are often informed by an underlying 
economic imperative of attracting and keeping readers, the basis of considerable 
advertising revenue (Weingart, 1998; Underwood, 2001). Thus, established news values, 
media frames, and economic imperatives fuel an increasing reliance on ‘market-oriented’ 
and ‘soft news’ stories emphasising emotion, sensation, and drama (Underwood, 2001; 
Nisbet et al., 2003). In the reproductive realm, fertility service users are the key source of 
such stories, and have an interest in garnering public and official support for their cause. 
In New Zealand, consumer groups actively campaign for increased public funding for 
fertility services and access to techniques and procedures unavailable locally, including 
PGD. Their willingly shared stories of struggle and loss, grief and hope make excellent 
copy for journalists eager to meet deadlines and fulfil audience expectations. Hence, the 
voices of consumers and consumer groups also tend to be well represented.  
News coverage of ARTs and related biogenetic developments is thus the co-
creation of journalists and their key sources, and this is clearly apparent within the 
growing body of research in this area (see Nelkin, 1987, 1996, 2001; Karpf, 1988; 
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Franklin, 1990; Stone, 1991; Einsiedel, 1992; Condit, 1994, 1996; Van Dijck, 1995, 
1998; Bauer, 1998; Nelkin and Lindee, 1998; Conrad, 1999; Brienbaum-Carmeli et al., 
2000; Huxford, 2000; Petersen, 2001; Priest, 2001; Seguin, 2001; Anderson, 2002; 
Nerlich et al., 2002; Nisbet and Lewenstein, 2002; Hamilton, 2003; Nisbet et al., 2003; 
Smart, 2003; Väliverronen, 2004). The general consensus is that since the 1980s, ARTs 
have been normalised as offering a welcome and relatively routine but still somewhat 
miraculous solution for desperate infertile couples (reflecting a pervasive consumer 
discourse), while biogenetic technologies have been heralded as offering virtually 
unlimited potential to prevent or ‘cure’ debilitating diseases and alleviate human 
suffering (reflecting the predominance of science discourse) -- although not without 
certain dangers. Frames of happiness and hopelessness pervade representations of the 
former -- again reflecting the perspective of service users -- while latter coverage 
emphasises frames of unbounded scientific development in the service of humanity, 
along with economic progress -- clearly reflecting the views of scientists and political 
advocates.  
 
 
Methodology 
 
Drawing on this body of work, the following discussion identifies the predominant media 
frames, narrative emphases and discursive strategies within New Zealand print media 
coverage of emerging reproductive and biogenetic technologies and their proposed 
regulation. This investigation focused on the largest circulation newspapers and 
magazines, including the daily national paper, The New Zealand Herald; national 
weeklies the Weekend Herald (with inserted Canvas magazine) and Sunday Star Times; 
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and four regional daily papers: the Otago Daily Times, Christchurch’s The Press, the 
Wellington-based Dominion Post (incorporating The Dominion and Evening Post), and 
the Hamilton-based Waikato Times. Also included were the following magazines: New 
Zealand Listener, New Zealand Woman’s Weekly, Next magazine, and New Idea, the 
last three all being high circulation women’s magazines.  
 
A search of two electronic databases, Index New Zealand and Newztext Plus, was 
undertaken to locate relevant articles addressing the issues of (in)fertility, IVF, sperm and 
egg donation, surrogacy, PGD, human cloning, and stem cell research. This search 
garnered a total of 170 newspaper and magazine articles. Each article was then subjected 
to content and narrative analysis to identify which technologies were featured and how 
extensively, their ascribed applications and implications, and degree of favourable 
representation, registered on a scale from 1--5. Recurring analogies, myths and metaphors 
were recorded, as were key themes, predominant narrative modes, the proportion of 
content comprising personal stories and technological details, the content and nature of 
any critique, its proportion and placement, and the affiliations of any commentators cited. 
This data was compiled in Excel spreadsheets and the sample analysed as a whole. 
 
 
Anecdotal Personalisation: The Human Drama Behind The News 
 
Overwhelmingly predominant in over two thirds of our sample was a media frame that 
Nisbet et al. (2003: 48) term ‘anecdotal personalization’, whereby the potential benefits 
and implications of emerging treatments and technologies are introduced and explored 
using the personal testimony of individuals as the primary frame of reference. Condit 
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(1994) describes this process as aestheticization, and suggests that these ‘real life’ stories 
invite readers to identify with characters and share in their personal struggles and 
triumphs. As noted by Karpf (1988), Conrad (1997) and Petersen (2001), anecdotal 
personalisation is used to create interest and make ‘high-tech’ procedures and 
technologies more relevant and personally meaningful to lay audiences by demonstrating 
their value for particular individuals. Problematically, however, this personalised focus 
often occurs at the expense of detailed technical information or contextualisation of the 
issues raised, with attendant risks of oversimplification and potentially misinforming the 
public about important details (Nisbet et al., 2003).  
In our sample, such personalisation generally took the form of ‘real life’ human 
interest stories typically featuring women and couples who have used, or been impeded in 
using, assisted reproductive and related biogenetic technologies to achieve a desired end -- 
in most cases, a biologically related child, but in some cases a child free from a particular 
genetic disorder, or simply of the ‘right’ sex. Not surprisingly, anecdotal personalisation is 
especially pronounced in the magazine stories, but is also strikingly evident within the 
newspaper reports. In at least two thirds of the articles, personal narratives constitute 50 
percent or more of total content. More than a quarter of the articles collected comprise 
almost entirely of ‘real life’ stories, with little (if any) additional commentary or discussion. 
In some cases, these stories are presented in a way that effectively endorses a new service, 
technique, or controversial research project (for example, The New Zealand Herald, 18 
May 2002; The Press, 8 May 2003; The New Zealand Herald, 9 August 2004), reflecting 
the concordance of interest between consumers and specialists and researchers.7 In others, 
personal narratives affirm the provisions of the HART Act regarding the recording of 
information about genetic origins (for instance, New Zealand Woman’s Weekly, 9 June 
2003; Canvas, 9--10 October 2004).  
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 The vast majority of stories, however, relate the struggles and triumphs of women 
and couples undergoing, or thwarted in their desire to undergo, fertility treatment. 
Significantly, approximately 95 percent of consumers represented are explicitly identified 
as in a married (heterosexual) relationship. As I discuss elsewhere, while lesbians, single 
women and gay men are significantly underrepresented in the personal stories related by 
local news media, the increasing use of ART to create families outside the heterosexual 
nuclear family norm was certainly subject to intensive discussion and at times scathing 
critique during the period surveyed (see Michelle, 2006b).  
As a key media frame, anecdotal personalisation permits some acknowledgement 
of the potential reality of using these technologies through the telling of detailed firsthand 
accounts. IVF, for example, is described by some recipients as a ‘long, uncertain road’ 
and ‘an exhausting process’ which takes an immense physical and emotional toll (Next, 
September 2003); others attest to lives that are ‘chronically disrupted’ during the IVF 
‘emotional roller-coaster’ (The Press, 8--9 June 2002). As local celebrity businesswoman 
Suzanne Paul describes it (having spent upwards of $60,000 on eight failed attempts), 
IVF is no walk in the park: ‘…I didn’t want to go out, didn’t want to see people…. I 
didn’t have the energy…. It knocked me about having all the drugs and hormones, made 
me really ill’ (New Zealand Woman’s Weekly, 15 July 2002). Many interviewees note 
the considerable financial costs involved – currently between NZ$7--10,000 per IVF 
cycle.   
 However, where such costs and difficulties are acknowledged, they are generally 
described as well worth it; a message reinforced by the typically positive narrative 
conclusion and often confirmed visually in photographs of the happy family. Cherry 
Lucas and husband Roy Henderson, for example, ‘endured’ six years of ‘embarrassments, 
stresses, frustrations and hurts, along with…the loss of much personal dignity’, but were 
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finally ‘rewarded’ with the birth of a smiling baby son (The Press, 8--9 June 2002). Even 
after spending $20,000 on twelve attempts at donor insemination, a beaming Victoria 
Quade is pictured under the extraordinary headline, ‘He was worth every dollar I spent’ 
(The Dominion Post, 16 August 2004), literally depicting this single mother as a ‘happy 
customer’ and her son as a commodity -- entirely in keeping with the consumer discourse 
underpinning this particular media frame. Indeed, the crudeness of this ‘market 
transaction’ is offset by the focus on personal stories, which invite readers to identify 
emotionally with those featured and to empathise with their human drama. Effectively, 
anecdotal personalisation reinforces the naturalness of using DI and IVF as a ‘solution’ to 
infertility, irrespective of the financial and emotional costs involved. Any consideration 
of alternative treatment or parenting options is also neatly sidestepped. As Franklin 
(1990) notes, happiness is the dominant narrative theme of such stories, rather than the 
risks, successes, or wider social implications of such technologies. Featured ‘characters’ 
are selected (either by journalists, or increasingly, by the public relations advisors of 
fertility clinics), not because they represent consumers in general, but because they ‘fit’ 
with a predetermined news angle. Thus, articles highlighting new techniques, treatments, 
or research programmes feature those who have been, or might be, aided by them, while 
articles addressing funding constraints relate the stories of those whose parental 
aspirations have been thwarted by official tightfistedness. 
 That anecdotal personalisation now constitutes the dominant media frame in local 
coverage of fertility issues is evident in the overwhelmingly upbeat coverage of New 
Zealand’s oldest mother, Mrs Lyn Mason, who twice gave birth in her mid 50s using 
donor eggs (see Waikato Times, 5 July 2003; The Press, 28 August 2004; The New 
Zealand Herald, 30 August 2004; Waikato Times, 4 October 2004). Such positive 
coverage, which included multiple front page features, editorials and numerous other 
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articles, represents a dramatic divergence from the more typical representation of older 
pregnant women as ‘rupturing feminine and maternal norms’ (Betterton, 2002: 256) and 
as ‘selfish or abnormal -- unless they are celebrity mums’ (Ibid: 260). Certainly, coverage 
of similar overseas cases has been far more critical, and it seems that the decision of the 
Masons to ‘tell their story’ largely determined the tone of subsequent media discussion, 
which effectively cast the Masons as central protagonists in a heroic narrative of tragedy 
and loss, followed by triumph; or as one editor put it, ‘A love story for our times’ 
(Waikato Times, 5 July 2003). Key details of their experience are compulsively reiterated 
in several articles -- including their early struggle to overcome infertility, only to meet 
with disaster 11 years later when their only daughter Kylie died in a car accident that also 
killed Lyn’s mother, and their eventual happiness at making their family complete once 
more. Clearly, this kind of ‘feel-good’ human interest story was regarded as highly 
newsworthy, resulting in significant media coverage. 
 Problematically, however, by retelling the Mason story almost purely in 
personalised terms, any meaningful consideration of the broader health, social and ethical 
issues raised by such cases (given low success rates, high risk of medical complications, 
and the long-term implications for the children of older parents) is effectively ‘squeezed 
out’ of media discussion, and in some cases explicitly countered via reference to 
disconfirming evidence drawn exclusively from the personal story featured. Indeed, any 
such objections are characterised by one editor as bordering on ‘prejudice and hysteria’ 
(Waikato Times, 5 October 2004). Extensive personalisation thus facilitates a broader 
process of discursive normalisation by affirming the legitimacy of this ‘special case’ as 
‘utterly normal’ (Ibid.), while simultaneously policing the boundaries of ‘legitimate’ 
older motherhood. Thus, what is considered a ‘normal’ use of ART and related 
technology depends entirely on what is considered acceptable in terms of ‘shared’ social 
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norms and values. Having a child at 55 is only normal if it occurs under the ‘right 
circumstances’ -- those of tragedy, loss, and utter blamelessness (Ibid.). Presumably, 
media coverage would have been less favourable had the Mason’s situation been due to 
Lyn’s ‘selfish’ desire to delay motherhood while pursuing a career, for instance. 
Fortunately, the extent of the Mason’s victimisation and blamelessness virtually 
guarantees them public and media sympathy. This very limited framework of 
acceptability will do little to comfort other older mothers, however, since most lack the 
Mason’s extraordinary extenuating circumstances.  
 With personalisation firmly established as the dominant media frame, newer and 
more controversial technologies such as PGD are similarly examined in terms of how 
they might benefit individuals and couples, as reflected in headlines such as ‘No Regrets 
For Parents Of First Designer Baby’ (Sunday Star Times, 15 September 2002). 
Frequently, anecdotal personalisation prevails to the exclusion of serious consideration of 
the wider social ramifications. Thus, stories such as ‘Kiwis Select Sex Of Babies In Oz’ 
(The Dominion Post, 14 September 2002) and ‘NSW Clinic Offers “Right” Sex Baby’ 
(The New Zealand Herald, 14 September 2002) highlight the experiences of New 
Zealanders ‘forced’ to go to Sydney to choose the sex of their child, while sidestepping 
any serious consideration of wider debates around sex selection. Several other stories 
feature couples with two or more children of the same sex who really want a change, and 
in all but one of these cases, a girl child is explicitly desired (see for example New 
Zealand Woman’s Weekly, 26 August 2002; Sunday Star Times, 1 December 2002a), 
thus implicitly countering public and political anxieties that the use of this technology 
might skew the general population in favour of boys.  
 Remarkably, one local specialist appears to have played a key role in promoting 
the personalisation of this issue. Dr Richard Fisher, founding director of New Zealand’s 
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largest private fertility service provider, Fertility Associates, is frequently cited on a 
range of reproductive issues, and clearly comprises a key source of expert commentary 
for journalists. Judging by the following comments, both Fisher and journalists are well 
aware of his capacity to shape public understandings of reproductive and related genetic 
technologies by actively ‘mediating’ their public representation: 
 
[I’ve] grown into this area, so I’ve watched it develop and it’s under my control, in 
a sense. I have two to three years to think about it before I signal it. You see, what I 
have done for the last 10 years is…raise it in the media, let everyone get over their 
knee-jerk reactions. You get an opportunity to personalise it…. Most people say, 
“Oh yuck, that’s not in the context of how I see the world” [referring to the use of 
pre-implantation genetic diagnosis for sex selection]. Give them three months to 
think about it and they can usually find someone in their peer group for whom it 
might have been a good idea. (Dr Richard Fisher, as cited in Weekend Herald, 14--
15 August 2004; emphasis added)  
 
 Here, Fisher appears to acknowledge exploiting the media’s reliance on anecdotal 
personalisation by bringing suitable cases to the attention of journalists, with the aim of 
providing points of identification for readers. What is more remarkable is that at this 
time, Fertility Associates was awaiting ethical approval to offer sex selection via PGD. 
Given many of the headlines that appeared during the course of this study, Fisher seems 
to have been relatively successful in shaping media coverage of the PGD issue -- if less 
so in influencing legislators. In this instance, the predominant emphasis on highly 
selective anecdotal personalisation marginalises feminist, ethical and social critiques of 
sex selection, and frames the parameters of public discussion in terms of the desirability 
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of PGD for family ‘balancing’ (Sunday Star Times, 1 December 2002b) -- the very 
grounds on which Fertility Associates sought to offer this service.  
 Further, while opposition to genetic selection from religious groups and the 
disabled is acknowledged in several reports (Sunday Star Times, 15 September 2002; The 
Dominion Post, 25 November 2004; The Press, 24 November 2004), the views of 
individual consumers and influential commentators are often drawn on to dismiss such 
concerns as unfounded. British reproductive specialist and international media celebrity 
Professor Robert Winston, for example, is quoted as strongly refuting the concerns of 
‘ethics campaigners’, describing them as ‘purists and scaremongers’: 
 
Winston has no time for talk of designer babies and eugenics. “People…just want 
babies, and healthy ones if they can. People are not going to go through the anguish 
of IVF to have a blue-eyed baby.” He should know. Over the course of his 64 years 
Winston has helped thousands of women have happy, healthy babies. (Christchurch 
Press, 7 July 2004; emphasis added).  
 
 On the issue of using PGD to select sex, Winston is equally adamant: 
 
…society has more to worry about than [couples] using PGD to balance up a family 
of four boys. “If you choose the sex of your child as a result of IVF, some people 
throw their hands in the air and say this is a terrible thing to do. But it’s actually not 
in any way going to change society.” (Ibid.; emphasis added)  
 
 Here, the fertility specialist is recast as mind reader, futurist, and social scientist, 
able to predict future consumer demand and also assess the long-term social 
 19
consequences of satisfying that demand. As Nelkin (1987) and Karpf (1988) note, it is 
relatively common for scientists who have become established media sources to be asked 
to comment on areas outside their expertise, and many do so. Hence, local expert Dr 
Richard Fisher is similarly cited adding his dismissive assessment of the proposed ban on 
sex selection via PGD: ‘If someone finds out that you can use a particular douche that 
works in the vagina to conceive a boy or girl, how can you ban that?’ (as cited in Sunday 
Star Times, 1 December 2002b). Of course, as a few local journalists did note, the 
development of technological means to determine sex in utero via amniocentesis has had 
a significant and seriously detrimental effect on the sex ratios of two of the world’s most 
populous and rapidly developing nations: India, where some parents are willing to flout 
the law to detect and subsequently abort unwanted girl children (Balakrishnan, 1994; 
Oomman and Ganatra, 2002); and China, where amniocentesis followed by selective 
abortion has now supplanted the more traditional practice of female infanticide (Hudson 
and den Boer, 2004). As these examples suggest, individual parental decisions can, 
collectively, have significant consequences for society as a whole -- a point that is largely 
discounted in local media reports through heavy reliance on ‘expert’ sources who are 
proponents of biogenetic technologies: It really doesn’t make a difference to society if 
parents choose to select for sex, argues Winston, and ‘he should know’. What is 
particularly extraordinary in local coverage of this issue is the almost complete absence 
of any political voice explaining the ethical rationale behind the proposed legislative ban 
on sex selection. Non-medical perspectives are also entirely excluded, giving the distinct 
impression that on this issue, the only voices that count are those of potential consumers, 
scientists, and local fertility specialists -- some of whom clearly stand to profit from 
offering such procedures.  
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 Winston’s and Fisher’s comments also attest to a strong element of science--
media symbiosis in this country; one that appears to enable prominent medical specialists 
to set the agenda for media representations of emerging biogenetic treatments and 
technologies in terms of how they might benefit the individual consumer, while neatly 
obscuring from public attention the other, financial interests that are also at stake in 
commercial fertility service delivery -- in this case, Fisher’s own interests as director and 
shareholder of Fertility Associates. Even more concerning, however, is the apparent 
complicity of local journalists in this process. Rather than exploring the wider 
implications of Fisher’s claims regarding his ability to use media to ‘signal’ and 
‘personalise’ new developments (particularly in light of traditional journalistic values of 
independence and integrity), the reporter concerned warmly describes the ‘very smooth, 
very serious, seriously empathetic’ Fisher as ‘very good at massaging…the movement of 
knowledge through the channels it takes to reach the public’ (Weekend Herald, 14--15 
August 2004). This suggests a degree of friendly collusion between fertility providers and 
journalists, with mutual acknowledgment of their shared interest in the reproduction of an 
established media frame.  
 Furthermore, anecdotal personalisation, backed up by selected ‘expert’ sources, 
highlights the potential benefits of emerging reproductive and biogenetic technologies for 
individuals and couples at the expense of due consideration of potential risks and broader 
social, ethical, and regulatory issues and implications, while also diverting attention away 
from the economic and political contexts within which such technologies are used and 
promoted (see also Karpf, 1988; Petersen, 2001). Serious examination of these wider 
issues is effectively ‘crowded out’ by the focus on ‘real life’ stories of individuals 
struggling to overcome loss or deficiency, or to gain access to services currently 
unavailable. In effect, personalisation sets the agenda for discussion in a way that limits 
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the kinds of questions that might be asked to just a few: ‘How can a pregnancy be 
achieved?’ (Franklin, 1990: 207) in the case of IVF and other ARTs, and ‘How can the 
right kind of baby be produced?’ in the case of PGD. Indeed, some reporters and editors 
may view these broader issues and implications as less relevant, since much of what is 
reported is subjective ‘personal experience’, and thus the only relevant issues are those 
that pertain specifically to featured individuals. In turn, these highly individualised 
personal narratives and the experiential ‘truths’ they seemingly reveal are presented as 
though standing in for and encompassing collective human experience. Having 
universalised the personal experiences of a few in this way, news media implies that the 
only relevant concern is that of how such technologies might benefit these particular 
individuals and couples, in some cases scarcely acknowledging other individuals directly 
affected. In the case of PGD, for example, there are potentially significant social, 
psychological and health consequences for ‘designer babies’ and ‘saviour siblings’, a 
point less frequently acknowledged in media coverage.  
 
 
Politicisation and The Campaign For Increased Public Finding 
  
With this media frame firmly in place, the groundwork is laid for fertility specialists and 
consumer groups to utilise media to facilitate the politicisation of service provision. 
Hence, use of ART becomes constructed as the personal choice of individuals and 
couples for whom genetic parenthood is a right, and for whom assistance is a now 
considered a legitimate need (Van Dijck, 1995). In a similar way, gaining access to 
emerging genetic technologies and treatments is framed as highly desirable and an issue 
of both choice and necessity. Indeed, some journalists appear to view the campaign to 
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increase public funding for fertility services as a worthy ‘cause’ that may be legitimately 
advanced, in keeping with the tradition of advocacy journalism. Numerous reports 
exclusively articulate the perspectives of fertility specialists and their ‘customers’, whose 
tragic personal circumstances are used to bolster calls for increased public funding, less 
restrictive eligibility criteria, or the provision of services currently unavailable locally.8 
The following example is not atypical:  
 
A letter to say they had been bumped off the waiting list for fertility treatment left 
the Hoogenboezem family with a choice. They had to find $8,000 to fund another 
round of fertility treatment that would hopefully result in a sibling for their 15-
month-old son, Jacob, or decide to call it quits on adding to the family… They have 
decided to call it a day…. Mrs Hoogenboezem said “It’s shattering — it’s so 
frustrating. How can they decide how many children we can have? We’re lucky to 
have had one son. But they are not providing us with a sibling for our son.” (The 
Press, 24 September 2002)  
 
 Such comments suggest fertility treatment is not simply about ‘curing’ a medical 
problem and addressing a patient ‘need’. Fundamentally, it is about satisfying people’s 
‘wants’ and demands as consumers. Here, the initial medical/social ‘problem’ of 
infertility or childlessness has been addressed, but merely fuels a subsequent demand to 
be ‘provided’ with at least one other sibling. In the process, assisted reproductive 
technologies and the children they may produce become (re)constructed as commodities 
that can be offered or withheld. As noted by Van Dijck, local journalism has become 
‘deployed by special interest groups to commodify and market IVF and related 
technologies, while simultaneously expanding and emphasizing the need for them by 
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pointing to the large number of infertile couples desperately waiting for treatment’ (Van 
Dijck, 1995: 76). Increasingly, consumer groups also draw on and incorporate elements 
of human rights discourse to bolster claims to their ‘fair share’ of public health funds, in 
some cases drawing on the principle underpinning the state’s financial support of 
women’s right not to bear children (through funding abortion) to strengthen assertions 
that the failure to empower those who do want children constitutes discrimination (The 
Dominion Post, 13 June 2002). Even Robert Winston weighs into the local political 
debate. Invited to New Zealand in July 2004 to speak to government officials and MPs, 
Winston argues that the state has a duty to provide the infertile with publicly funded 
treatment ‘because [infertility] causes them as much pain -- if not more -- as having an 
arthritic knee’ (The Dominion Post, 8 July 2004). 
 Without discounting the distress felt by many childless individuals, one potential 
consequence of this politicisation of service provision is that it distorts the reality of 
fertility treatment by implying that the primary barrier to success is financial rather than 
medical, biological or technological, and thus that continued childlessness is due to 
constraints on public or private funding, rather than a failure of the technology itself, 
which continues to have reasonably low success rates among many (particularly older) 
women. In the dozen or so ‘real life stories’ where a happy ending was not forthcoming 
in the form of a ‘take-home’ baby, responsibility was in all but two cases ascribed 
directly or implicitly to the failure of Government to fund subsequent IVF cycles, or to 
exclusive funding criteria, both of which were said to ‘force’ couples to ‘abandon’ their 
quest for a biological child, thus ‘putting their dreams on hold’ (The Dominion, 11 June 
2002; The Press, 26 September 2002; The Dominion Post, 13 July 2004). Couched in this 
ascription of responsibility is an assumption that IVF will eventually lead to a successful 
outcome for all, so long as they keep trying -- a false and potentially dangerous 
 24
misrepresentation, but nonetheless a lucrative one for fertility service providers, since it 
may encourage wealthier couples to undertake numerous unsuccessful cycles at their own 
expense.9 
 Thus, news media frequently serves as a vehicle for consumers’ calls for an 
increased share of public reproductive health funds, justified on the basis of lengthy 
waiting lists, growing market demand, and the presumption that everyone can eventually 
achieve a successful outcome. Ironically, the same statistics that expose IVF as a 
relatively unsuccessful treatment (per cycle) are at times mobilised to support the call to 
fund subsequent treatments, suggesting that while a concordance of interest exists 
between fertility specialists and consumers, these groups do retain separate interests of 
their own: ‘Mrs Scott hoped the number of publicly funded in vitro fertilisation cycles 
would be raised from one to three -- one gave couples a 38 per cent chance of becoming 
parents, but three boosted their chances to 70 per cent’ (The Dominion Post, 13 June 
2002). The logic here is clear, as Van Dijck (1995) notes: since the chance of success 
increases with subsequent cycles, women should undergo repeat cycles to improve their 
odds, thereby confirming IVF as a ‘successful’ technology whilst neatly obscuring the 
number of treatment cycles that may be required to achieve the desired outcome. Thus, 
medical rhetoric, often expressed through gambling metaphors calculating the ‘odds’ of 
success, is ‘deployed to authorize a political demand: government should help increase 
the effectiveness and efficiency of medical technology, and alleviate the financial burden 
of infertile couples’ by footing the bill (Van Dijck, 1995: 122). The ‘problem’ of ART 
thereby becomes political, as opposed to medical or ethical.  
 Further, the dominant voices in the funding ‘debate’ are those of consumers and 
the national lobby group representing their interests -- Fertility New Zealand (FNZ). 
Significantly, nearly half the annual income of FNZ is derived from an Australasian IVF 
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Directors Group grant of $16,764 -- a considerable investment (FNZ Financial Statement, 
2004). Fertility providers, and most notably senior staff of Fertility Associates, are also 
intimately involved in FNZ as members of its executive committee, attending its annual 
conferences, and participating in its AGMs. For its part, FNZ very effectively agitates for 
public funding of three treatment cycles. If successful, benefits would accrue not only to 
the infertile, but also to Fertility Associates as holder of public contracts in several main 
centres, significantly increasing their clientele and providing a secure basis for further 
growth, expansion, and ultimately profits. That this questionable financial and executive 
relationship between New Zealand’s largest service provider and a major lobby group has 
entirely escaped the attention of local media again reflects the concordance of interest 
between journalists, specialists, and consumers. Such concordance is also evident in 
extensive ‘technoboosterism’. 
 
 
Technoboosterism: Hyping Up the Benefits of Technological Innovation 
  
In contrast to the findings of Van Dijck (1995), the articles in our sample do not articulate 
science discourse to any great extent. Technical details of procedures and descriptions of 
how research was done comprise less than 25 percent of total content in around 90 
percent of the articles collected. Where it does occur is in articles relating to newer and 
less well understood procedures and techniques, such as human embryo cloning, stem 
cell research, and PGD. Thus, it appears New Zealand journalists have not followed the 
trend toward an increasing ‘technologization’ (Condit, 1994) of science reporting that 
occurred in some other countries during the 1990s, or perhaps do so to a lesser extent, 
preferring media frames that have greater appeal to readers.  
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 Rather than technologisation, a more predominant media frame is that of 
‘technoboosterism’ (Parrott and Condit, 1996: 8). That is to say, key sources, established 
news values and professional routines all encourage reporters to exhibit a pro-technology 
bias, leading them to emphasise the positive benefits of new scientific and biomedical 
developments, and to ‘overrate and overhype “high-tech” solutions’ (Ibid.). 
Technoboosterish coverage typically represents medical and scientific research as 
progressive, beneficial, and as offering hope of imminent cures for the sick and afflicted. 
Often, purely hypothetical future benefits of emerging technologies and treatments are 
emphasised and celebrated as though they inevitably emerged from the unstoppable 
march of scientific progress (Van Dijck, 1995, 1998). Conversely, as Petersen (2001: 
1263) notes, ‘potential disadvantages and dangers are either ignored or provide only a 
minor sub-theme’.  
 Frequently, professional journalistic values of balance and objectivity are set 
aside in favour of a heavy reliance on reproducing the largely unchallenged self-
representations and commentary of medical and scientific ‘experts’ (see also Nelkin, 
1987; Lewenstein, 1995; Nisbet and Lewenstein, 2002; Smart, 2003), possibly reflecting 
a lack of experience and scientific knowledge among local journalists (Lealand, 2004), 
who may not know whom to ask for independent confirmation or a divergent opinion 
(Friedman, 1986; Nelkin, 1987). Indeed, such is the authority conveyed to these ‘experts’ 
that independent confirmation is often regarded as unnecessary: as Nelkin (1987) 
suggests, journalists often regard science as ‘the ultimate authority’ (see also Karpf, 
1988; Hansen, 1994, cited in Petersen, 2001). It is also common for a small number of 
positive research findings relating to the therapeutic uses of stem cells in particular to be 
highlighted and then extrapolated or ‘telescoped’ (Parrott and Condit, 1996) to 
hypothetically encompass potential treatments for the full range of chronic and genetic 
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disorders, with journalists frequently reiterating the unqualified declarative statements of 
a few cited experts.  
  Thus, the tone of much local reporting is favourable, and at times overwhelmingly 
so. Just over two thirds of the articles are strongly or predominantly favourable towards 
the particular technology(s) discussed, while just one sixth are predominantly or strongly 
negative; the rest appear mixed or neutral. Most of the negative stories relate to more 
contentious issues such as genetic selection, embryonic stem cell research, and 
xenotransplantation, and often emphasise the urgent need for regulation in these areas. 
More common are stories that appear to be framed by a discourse of ‘great promise’ 
(Kitzinger & Reilly, 1997: 322) and thus depict reproductive and genetic technologies as 
offering boundless hope to the infertile, or imminent cures for those afflicted with 
debilitating diseases. Often, experts are cited at length attesting to the ‘revolutionary’ 
nature of their own and others’ ‘groundbreaking’ or ‘cutting-edge’ work, described as 
having achieved a ‘massive breakthrough’ offering ‘incredible’ or ‘enormous’ benefits to 
‘millions of people’ in terms of improving fertility treatment or preventing chronic 
diseases. For example, Australian scientist Professor Alan Trounson is cited proclaiming 
that ‘A revolutionary technique of making artificial eggs and sperm holds the key to 
eradicating infertility within 10 years,’ and ‘I’m certain that in the long term we’ll be able 
to help everybody’ (The New Zealand Herald, 30 July 2003; The Press, 2 September 
2004). Other stories make glowing references to ‘disease-busting stem-cell work’, touted 
in some articles as potentially offering ‘a super cure’ or ‘miracle cure-all’ (Weekend 
Herald, 16--17 October 2004). In many of these articles, the nature and significance of 
stem cell research is related with breathless excitement: 
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 The Holy Grail of medical science is all down to the discovery of the existence of 
stem cells…. Their possible uses are simply incredible. Damaged or diseased 
tissue…could be repaired or replaced with new tissue grown from master cells…. 
No need to worry about a lack of suitable organs or the risk of rejection -- just grow 
a replacement heart, liver, or kidney to slot straight in…. Children could be 
engineered for resistance to cancer, heart disease, mental illness, Aids and other 
human plagues. They could also be designed for superhuman strength, sunny 
disposition, flawless beauty or photographic memory. (Weekend Herald, 17--18 
May 2003) 
 
  As this example suggests, a pervasive technoboosterism dominates local 
coverage of stem cell research, in some cases leading to inaccuracy, exclusion, and 
distortion. While considerable debate continues among scientists about the ethics, 
significance and likely benefits of human stem cell research, such internal discussion and 
debate is only rarely acknowledged. The voices of scientists opposed to embryo cloning 
for this purpose, or even of those who question the ‘hype’ surrounding therapeutic uses of 
stem cells given unpredictable results (including stem cells turning into tumours), are 
infrequently acknowledged and largely confined to just two feature articles, an opinion 
piece entitled ‘Why Superman Is A Poor Saviour For Superhuman Research’ (The New 
Zealand Herald, 27 February 2003), and a lengthy feature article headed ‘Supercells Key 
To Regeneration’ (Weekend Herald, 16--17 October 2004). Rather more commonly, stem 
cell therapies are represented as the inevitable next step in the unstoppable march of 
scientific progress and development, and as indisputably offering medical benefits and 
cures for all (see also Van Dijck, 1995; Petersen, 2001). Science, we are told, will 
eventually fix everything and has endless capacity to eradicate disease for the betterment 
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of human kind. As Professor Trounson predicts, ‘It hasn’t happened yet, but it will’ (The 
New Zealand Herald, 30 July 2003).  
 This study thus confirms findings by Durant et al. (1996), Nelkin and Lindee 
(1998), Conrad (1999), Nelkin (2001), and Petersen (2001), who note that media 
personnel often uncritically reproduce claims made by specialists and scientists about the 
social value of their own work, and frequently fail to ask technical questions regarding 
the tangible benefits, safety, reliability and potential hazards of biogenetic medicine. 
Such uncritical acceptance reflects a taken-for-granted assumption that scientific 
knowledge is objective and disinterested, and thus that those conducting the research or 
offering a new biogenetic service can also legitimately evaluate its importance and 
potential significance. The failure of many journalists to acknowledge the social, political 
and economic contexts in which service provision and scientific research takes place 
means many are literally unable to perceive that the self-reporting of fertility specialists 
and scientists is often highly interested (see Nelkin, 1987; Weingart, 1998), and allows 
those sources considerable leeway to shape the agenda for how new developments are 
understood and debated in the public domain (Karpf, 1986; Nelkin, 1987) -- as clearly 
witnessed locally in the cases of PGD and cord banking (see Sullivan et al., 2005; Philp, 
2005; and Michelle, 2006a for further discussion). 
 More problematically, given the commercialisation of reproductive and 
biogenetic medicine in New Zealand, the reliance on a few influential sources enables 
prominent specialists to utilise their close relationship with media personnel to fuel 
consumer demand for new and expensive, medically non-essential services from which 
they potentially profit professionally and financially (see also Condit, 1996). Several 
articles feature fertility specialists extolling the virtues of services they themselves have 
developed; including CordBank, the subject of a recent exposé (Philp, 2005), and more 
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recently egg freezing and Egg Check. These ‘news stories’ effectively offer private 
service providers a form of free ‘institutional advertising’ in the guise of news (Van 
Dijck, 1995). Significantly, two of these new services seem specifically primed to 
capitalise on the anxieties of ‘women who have put careers ahead of starting a family and 
are concerned their biological clock is ticking’ (The New Zealand Herald, 14 September 
2004). But why get your eggs checked, when for a mere $7,000 you could have them 
cryogenically preserved? (Weekend Herald, 5 August 2004). Having already sown the 
seeds of insecurity among career women by actively promoting the message that 
infertility is largely ‘caused’ by leaving motherhood too late (The New Zealand Herald, 
22 April 2002; The New Zealand Herald, 4 November 2002), media actively promote the 
message that the fertility industry offers various solutions to women’s ‘self-inflicted’ 
problem. What is more, since women can never know if they have ‘good eggs’ or not, 
every woman over 30 becomes a potential customer for such services, so long as she can 
foot the bill.  
 
 
Discursive Normalisation 
 
As privileged sources, specialists and researchers are able to utilise media to police the 
boundaries of ‘acceptable’ science and quell public anxieties about some scientists ‘going 
too far’. In the present study, this was most evident in media coverage of human 
therapeutic and reproductive cloning. As noted by Petersen (2001: 1265), Australian 
scientists made a concerted effort via news media during the late 1990s to ‘extol the 
medical virtues of cloning research, and emphasise the distinction between “therapeutic 
cloning” -- implicitly seen as “good”, useful, and legitimate -- and “reproductive cloning” 
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-- seen as “bad”, dangerous, or illegitimate’. In turn, editors and journalists echoed the 
same good/bad science distinction, reinforcing this boundary work and engaging in 
various discursive containment strategies.  
 Based on our sample, it appears similar processes are occurring locally. The 
cloning of human embryos, for instance, is described by one local editor as ‘a triumph of 
principled science’, whilst experiments in human reproductive cloning are dismissed as 
‘irresponsible, unethical adventuring’ by a few ‘rogue scientists’, and an ‘affront to 
nature’ that ‘could scupper legitimate research’ (The New Zealand Herald, 2 January 
2003). Claims of the birth of ‘Eve’, the first human clone, are similarly debunked and 
contained in extensive media coverage, and are explicitly rebutted by ‘legitimate’ 
scientists keen to preserve the positive public image of therapeutic cloning in the face of 
potential contamination by ‘wacko’ religious cults and scientific ‘mavericks’ (The New 
Zealand Herald, 15 January 2003). Indeed, the general tenor of much reporting on the 
cloning issue is one of concern about how such experiments might affect ‘legitimate’ 
research on therapeutic cloning (The New Zealand Herald, 13 January 2003).  
 Yet, surprisingly, local media coverage also reflected some effort to normalise 
human reproductive cloning by explicitly equating this process with the natural 
occurrence of embryo splitting or twinning in utero. The Dominion Post (25 May 2002), 
for example, explains that ‘Identical twins start as one entity after fertilisation, a single 
cell, which later divides into two cells, each of which grows into a human, each 
containing the same DNA. That’s what a clone is, by definition, whether created in a 
laboratory or conceived naturally’ (emphasis added). This discursive conflation is 
repeated in several articles (see, for example, The Dominion Post, 9 November 2002; The 
Evening Post, 25 May 2002), and relies on a reductive logic in which both processes are 
conceived solely in terms of the replication of DNA at the precise moment in which ‘one’ 
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becomes ‘two’, thereby entirely ignoring the vastly different contexts in which such 
‘twinning’ occurs, along with the purposes of DNA replication in reproductive cloning 
and the potential health, social and psychological implications for any cloned offspring. 
This conflation thus serves to obscure some extremely important distinctions; yet it 
appears with startling regularity. A Dominion Post feature entitled ‘Human Clones Talk 
About Their Lives’ (25 May 2002), for example, asserts that ‘While Governments 
worldwide speak out against human cloning, real-life examples abound -- we call them 
identical twins’, and cites (among others) the views of local comic performers, The Topp 
Twins, much loved by New Zealanders and stars of their own television series.  
 Importantly, the notion that twinning and cloning can be equated by reducing both 
processes to a single moment abstracted from any context derives, not solely from the 
imaginations of journalists, but from the discourse of scientists themselves, including 
Winston, who later warns against banning human reproductive cloning, since it is 
‘impossible to do it’, but still feels the need to throw in an assurance, just in case: ‘But 
even if they did clone a human, you’d have to say so what? There are 2,500 human 
clones walking around in New Zealand right now. They’re called identical twins’ (The 
Press, 7 July 2004; emphasis added). Such problematic assurances may usefully help 
quell public anxieties and prevent a widespread backlash should the ‘impossible’ ever 
eventuate, while also offering assurances of the inherent benevolence of scientific 
investigation and the natural caution of ‘legitimate’ scientists like Winston. This kind of 
active management of public perception and response is vitally important for the conduct 
of science at a time when its goals and methods are being subjected to greater political 
scrutiny and official regulation than ever before -- as reflected in the Council of Europe 
Protocol to the Convention on Biomedicine and Human Rights banning human 
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reproductive cloning, and the US-backed Costa Rican proposal to ban all forms of human 
cloning, including therapeutic, via the UN, tabled in October 2004.  
 
 
Concluding Remarks 
 
It appears local media do provide a forum in which specialists and scientists are able to 
effectively advocate in support of their work and services, with little interrogation of their 
claims, and in many cases with active support from journalists and consumer lobby 
groups. Critiques of the technologies and their potential uses or wider implications are in 
the vast majority of cases very limited, comprising less than 25 percent of the total 
content in 80 percent of the texts collected, if present at all.10 Where such critiques or 
‘counterdiscourses’ (Van Dijck, 1995: 20) are voiced, however, articles often devote 
considerable space to debunking such concerns and rearticulating the medico--scientific 
rationale justifying a new technology or controversial line of research. This is also noted 
by Priest (2001: 6), who observes that ‘other voices…may be reported to create the 
appearance of a “balanced” story, yet they are subtly positioned as representing fringe (if 
not lunatic) perspectives. They are included only to be delegitimized.’ The views of 
specialists and scientists are thus frequently mobilised in ways that effectively dismiss or 
marginalise objections as deeply conservative, misinformed, or politically interested. As 
Winston remarks, ‘Those set against reproductive technology tend to be a minority…who 
have strong views on the nature of the embryo generally and work on an ethical 
framework not shared by most people in Western society’ (The Press, 7 July 2004). 
Thus, while New Zealand media is to some extent multi-vocal in the sense of 
articulating a limited selection of perspectives, the representational strategies adopted 
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more frequently serve to define and delimit the nature of public discussions, and to 
marginalise the voices of social, political, ethical and religious critique -- much more so 
than may be the case in other national contexts (see for example Einsiedel, 1992; 
Birenbaum-Carmeli et al., 2000; Smart, 2003). Extensive anecdotal personalisation 
privileges an individualised frame of reference that sidelines detailed consideration of the 
social and ethical implications of emerging technological developments, while also 
fuelling the ongoing politicisation of fertility service provision, which increasingly 
incorporates genetic technologies such as PGD. Local print media also offers 
predominantly positive representations of reproductive and biogenetic technologies, 
frequently echoing the voices of scientists and researchers themselves as they actively 
promote the value of their work, and with little interrogation of their technoboosterish 
claims, thereby facilitating the process of discursive normalisation of more controversial 
developments and emerging areas of research.  
This pro-science and technology bias leads local media to be relatively uncritical 
of emerging developments in these areas. Fewer stories engage with the legal, social and 
ethical questions raised by emerging technologies, including the commodification of 
children, the psychological consequences of genetic selection, and the ethics of human 
cloning research. The potential long-term risks associated with cryopreservation of eggs 
and embryos, sperm injection, PGD, cloning and xenotransplantation are rarely 
acknowledged, or are dismissed as insignificant. Where the costs of IVF and its limited 
success rates are noted, this often occurs within the context of highly politicised calls for 
increased public funding. With few exceptions, in-depth interrogation of the goals, 
techniques and potential social implications of reproductive and genetic technologies 
remains muted. Little space is devoted to critical evaluation of whose interests are at 
stake in the development and growing commercialisation of reproductive and genetic 
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technologies, in calls for increased public funding or the provision of a new service, and 
in the pursuit of particular lines of research (see also Van Dijck, 1995). 
These tendencies within local media reflect the concordance of interest that exists 
between media personnel, scientists and specialists, and consumer groups. As Condit 
(1994) notes, while each of these groups retains separate interests of their own and none 
is internally homogeneous, any major differences are offset by a stronger and more 
immediate mutual interest in the positive representation of reproductive and biogenetic 
technologies. Consumers have an interest in telling their stories to journalists, as doing so 
helps build public support for their cause of increasing public funding and securing the 
provision of services not yet available here. The often heart-wrenching stories they tell 
make for great newspaper copy: hence the predominant use of anecdotal personalisation 
as a media frame.  Fertility specialists and scientists need to emphasise the positive social 
and medical value of their work to gain public acceptance, funding, and in the New 
Zealand case, legislative and ethical approval of new procedures or lines of research. 
Stories about how a given procedure or research project may help desperate couples 
realise their parental aspirations (or put an end to debilitating diseases) foster public 
enthusiasm and reassure funding agencies and legislators of the potential benefits of 
supporting their work. For their part, magazine and newspaper editors and owners seek 
increased market share, and both kinds of stories -- ‘real life’ human interest stories and 
‘pioneering quests’ -- make for compelling reading. Such stories are highly newsworthy; 
they help sell papers and magazines. Thus, all three groups have immediate and direct 
interests at stake, and all have something to gain (Condit, 1994).  
The representational strategies adopted by media in framing issues around 
reproductive and biogenetic technologies thus ‘speak’ to the interests of all three groups, 
and are to some extent mutually reinforcing. As the lynchpins in this symbiotic triad or 
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concordance, journalists adopt representational frames of anecdotal personalisation and 
technoboosterism, which in turn facilitate the politicisation and discursive normalisation 
of current and emerging treatments and technologies. While audience reception was not 
the object of investigation here, these media frames potentially aid in manufacturing 
consent to new biomedical and scientific developments by defining and delimiting their 
public representation. In the process, most media marginalises serious critical discussion 
of the nature, intent, and potential implications of such developments and the economic 
and political interests at stake. The predominance of these media frames thus militates 
against full and balanced discussion of the wider societal implications, social value and 
potential risks of ART, PGD, stem cell research, and cloning, instead constructing 
emerging reproductive and genetic technologies as the products of a generally benevolent 
scientific establishment and as offering significant future benefits for individual 
consumers, and by extension, society as a whole. In this respect, New Zealand media 
serves as a crucial nexus in the articulation of medical, scientific and consumer 
discourses and potentially also as a key site for forging public acceptance of emerging 
and deeply controversial developments in reproductive and biogenetic medicine. 
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Notes: 
 
1 The title of this paper is taken from a Dominion Post feature article entitled ‘Human 
Clones Talk About Their Lives’ (25 May 2002). 
2 A popular misnomer; Louise Brown was actually conceived in a petri dish. 
3 Concerns about the latter were compounded in May 2002 when Italian reproductive 
specialist Severino Antinori announced the successful implantation of several cloned 
embryos, sparking outrage among the international scientific community. Within 
months, these claims were followed by (unsubstantiated) proclamations by the 
Raelians (an alien-worshiping religious cult) of the birth of ‘Eve’, supposedly the first 
human clone. 
4 The Act also makes mandatory the recording of information about sperm, egg and 
embryo donors, recipients and offspring, and makes it possible for offspring to 
discover the identity of their donor parent(s) at age 18.  
5 Regular national surveys of New Zealand journalists suggest a feminised and 
comparatively youthful local workforce (Lealand 1998, 2004). While 60 per cent of 
local journalists have completed a university degree, most degrees were in the arts or 
social sciences, and only seven percent of these were Masters degrees (Lealand, 
2004). The dwindling number of senior journalists has sparked concerns about 
declining skill levels and journalistic standards, loss of institutional memory, and a 
lack of critical acumen within the profession as a whole (Ibid.). 
6 While a ‘preferred’ reception cannot be guaranteed, since readers may be able to 
draw on other sources of knowledge such as personal experience and professional 
expertise, the specialised nature of recent medical and scientific developments means 
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most people will lack useful alternative sources of information. Hence, the media is 
likely to exert a major influence on public understandings in this area. 
7 Since many of these articles include details of how to contact the service providers 
or researchers, along with information about individuals using the service or 
participating in (presumably confidential) drug trials, they are likely to be the result of 
approaches made to media by the researchers and clinics themselves. This is clearly 
the case with CordBank, promoters of which appear to have issued tailored press 
releases to numerous regional newspapers. Without exception, the published articles 
included a compelling personal story featuring a satisfied customer from each locality, 
suggesting that the contact details of these customers were also issued to journalists 
(see Michelle, 2006a). 
8 See for example Waikato Times, 15 June 2002; The Press, 26 September 2002; The 
Dominion, 11 June 2002; The New Zealand Herald, 6 September 2004; The 
Dominion Post, 7 September 2004 and 11 November 2004.  
9 In my personal communications with fertility counsellors and specialists, I have 
heard of couples undergoing as many as 13 IVF cycles; only one or two of which are 
likely to have been publicly funded. 
10 The most commonly articulated objections are moral or religious in nature, and are 
raised by the Catholic Church, other Church groups, ‘pro-lifers’, the New Zealand 
Inter-Church Bioethics Council, and to a lesser extent ethicists and disabled groups. 
Most objections concern the use of PGD for purposes of genetic selection, embryo 
research, and xenotransplantation or gene mixing (see for example The Dominion 
Post, 27 August 2004 and 25 November 2004; The Press, 24 November 2004). 
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